![Ansbert Gadicke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ansbert Gadicke
Fondateur chez
MPM BioImpact LLC
Profil
Ansbert K.
Gadicke founded MPM BioEquities Adviser LLC in 1997, where he worked as Managing Director from 1997 to 2010, Cerimon Pharmaceuticals, Inc. in 2004, where he worked as Director from 2004 to 2011, and MPM BioImpact LLC in 1992, where he is working as Managing Partner from 1992.
Dr. Gadicke also founded ReNAgade Therapeutics, Inc. Dr. Gadicke also currently works at Orna Therapeutics, Inc., as Chairman, Reunion Neuroscience, Inc., as Chairman, Mindset BioPharmaceuticals Ltd., as Director, and various other companies.
Dr. Gadicke also formerly worked at Solasia Pharma KK, as Chairman, BioMarin Pharmaceutical, Inc., as Director from 1997 to 2001, ViaCell, Inc., as Director, and various other companies.
Dr. Gadicke received his doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Postes actifs de Ansbert Gadicke
| Sociétés | Poste | Début |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Fondateur | 01/01/1992 |
Mindset BioPharmaceuticals Ltd.
 Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Develops disease modifying therapies | Directeur/Membre du Conseil | - |
MPM BioVentures V GP LLC | Corporate Officer/Principal | - |
MPM BioVentures V LLC | Corporate Officer/Principal | - |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | - |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Directeur/Membre du Conseil | - |
MPM Oncology Impact Management LP
 MPM Oncology Impact Management LP Investment ManagersFinance OIM’s funds make primarily long-term venture capital and equity-related investments in publicly and privately-held companies doing business in the life-sciences industry, including within the oncology and pharmaceutical sectors. | Corporate Officer/Principal | 01/01/2015 |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Président | - |
Cullinan Pearl Corp.
 Cullinan Pearl Corp. BiotechnologyHealth Technology Develops an orally available tyrosine kinase inhibitor | Directeur/Membre du Conseil | - |
| ░░░ ░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Ansbert Gadicke
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Ansbert Gadicke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
55
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 55 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
MPM BioEquities Adviser LLC
 MPM BioEquities Adviser LLC Investment ManagersFinance MPM BioEquities Adviser focuses exclusively on global life sciences investments. The firm invests in biotechnology, specialty pharmaceuticals, medical technology and related companies that provide innovative medical products and services to the healthcare industry. They invest across all geographies, stages of development and therapeutic areas. MPM focuses on inflection points in the development of companies, such as the achievement of clinical proof-of-concept data and the achievement of early commercial success, and on reinvigorating commercial platforms with potentially high growth assets. MPM BioVentures I (BB BioVentures, MPM BioVentures Parallel Fund) is a family of funds that was launched in 1997 and is no fully committed with 75% of its investments in biotechnology and 25% in medical devices and other healthcare related fields. The MPM BioVentures I portfolio consists of 26 companies with investments ranging from $5 million to $20 million per company. Within the biotechnology sector, the funds' investments are split between companies focused on therapeutics and enabling technologies. About 80% of the funds' assets are invested in US companies and 20% in European companies. The MPM BioVentures II family of funds closed in the first quarter of 2000. The funds consist of investments in biotechnology, medical devices and other healthcare related fields. The MPM BioVentures II has invested in 35 companies, with investments ranging from $10 million to $50 million. The fund has invested across the entire spectrum of company development, from start-up through mezzanine and PIPES. 85% of the funds' investments are in US companies and 15% are in European and Asian companies. The MPM BioVentures III Fund closed in December of 2002. The fund holds a portfolio of 39 companies, 85% of which are focused on biotechnology and pharmaceutical products and 15% are focused on medical devices and life science tools. The fund's balanced portfolio of early-, mid- and late-stage companies includes investments in public companies through PIPE transactions. The MPM BioVentures IV family of funds was launched in the second quarter of 2006. The funds hold a portfolio of 18 companies with investments ranging from $5 million to $36 million. About 75% of the funds' investments focus on biotechnology and pharmaceutical products and 25% focus on medical device companies. About 25% of the funds' investments have been made outside the US, including investments in Asia and Europe. The MPM BioVentures IV family of funds serves as the lead investor in a majority of its investments and takes an active role as a board member on its portfolio companies' boards of directors. | Finance |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Omrix Biopharmaceuticals, Inc.
 Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Health Technology |
Clinical Ink, Inc.
 Clinical Ink, Inc. Internet Software/ServicesTechnology Services Operates as an eSource platform and provides clinical trial solutions | Technology Services |
Sideris Pharmaceuticals, Inc.
 Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on development of therapeutics for the treatment of transfusion-related iron overload | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Miscellaneous |
Xanodyne Pharmacal, Inc.
 Xanodyne Pharmacal, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for oncology, hematology, and pain management | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Kourion Therapeutics
 Kourion Therapeutics Miscellaneous Commercial ServicesCommercial Services Researches and develops initiatives for stem cell technology, used for the regeneration of cardiac, neuronal, hepatic and bone tissues | Commercial Services |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Researches drug development | Commercial Services |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Develops disease modifying therapies | Health Services |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services Offers biomedical research services | Health Services |
Solasia Pharma KK
 Solasia Pharma KK Pharmaceuticals: MajorHealth Technology Engages in the development, sale, import and export of pharmaceutical products and medical devices | Health Technology |
MPM BioVentures V LLC | |
MPM BioVentures V GP LLC | |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Dragonfly Sciences, Inc.
 Dragonfly Sciences, Inc. BiotechnologyHealth Technology Develops biosimilar products of monoclonal antibodies and soluble receptors | Health Technology |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
OSS Healthcare, Inc. | |
RWHD, INC | |
TriNetX, LLC
 TriNetX, LLC Data Processing ServicesTechnology Services Provides healthcare and life science data & platform solutions | Technology Services |
Raze Therapeutics, Inc.
 Raze Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops oncology therapeutics | Health Technology |
Florida Healthcare Analytics, Inc.
 Florida Healthcare Analytics, Inc. Packaged SoftwareTechnology Services Provides mobile applications for clinical trial patient engagement and electronic patient reported outcomes | Technology Services |
MPM Oncology Impact Management LP
MPM Oncology Impact Management LP Investment ManagersFinance OIM’s funds make primarily long-term venture capital and equity-related investments in publicly and privately-held companies doing business in the life-sciences industry, including within the oncology and pharmaceutical sectors. | Finance |
UBS Oncology Impact Fund
 UBS Oncology Impact Fund Investment ManagersFinance Functions as a family of funds | Finance |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
MPM Sunstates GP Managing Member LLC | |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Health Technology |
Cullinan Pearl Corp.
Cullinan Pearl Corp. BiotechnologyHealth Technology Develops an orally available tyrosine kinase inhibitor | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Commercial Services |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary delivery technologies to unlock previously inaccessible cells | Health Technology |
Choisissez Zonebourse 
